Psychometric evaluation of the altered states of consciousness rating scale (OAV)

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Studerus, Erich ^a   Gamma, Alex ^a   Vollenweider, Franz X ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; KETAMINE; PSILOCYBINE;

ADULT; ALTERED STATES OF CONSCIOUSNESS RATING SCALE; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; EXPERIMENTAL STUDY; FACTORIAL ANALYSIS; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; MALE; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; STRUCTURAL EQUATION MODELING; VALIDITY; CLINICAL TRIAL; CONSCIOUSNESS; DRUG EFFECT; METHODOLOGY; REPRODUCIBILITY; THEORETICAL MODEL;

ADULT; CLUSTER ANALYSIS; CONSCIOUSNESS; FEMALE; HUMANS; KETAMINE; MALE; MODELS, THEORETICAL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSILOCYBINE; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 77957942620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012412     Document Type: Article

References (91)

1. Dittrich A (1998) The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31: 80-84. 10.1055/s- 2007-979351.
2. Dittrich A (1975) Zusammenstellung eines Fragebogens (APZ) zur Erfassung abnormer psychischer Zustände [Construction of a questionnaire (APZ) for assessing abnormal mental states]. Z Klin Psychol Psychiatr Psychother 23: 12-20.
3. Dittrich A (1985) Ätiologie-unabhängige Strukturen veränderter Wachbewusstseinszustände. Ergebnisse empirischer Untersuchungen über Halluzinogene I. und II. Ordnung, sensorische Deprivation, hypnagoge Zustände, hypnotische Verfahren sowie Reizüberflutung [Etiology-independent structures of altered states of consciousness. Results of empirical studies on hallucinogens of the first and second order, sensory deprivation, hypnagogic states, hypnotic procedures, and sensory overloadm]. Stuttgart, Germany: Enke.
4. Dittrich, A (1996) Ätiologie-unabhängige Strukturen verä nderter Wachbewusstseinszustände.Ergebnisse empirischer Untersuchungen über Halluzinogene I. und II. Ordnung, sensorische Deprivation, hypnagoge Zustände, hypnotische Verfahren sowie Reizüberflutung [Etiology-independent structures of altered states of consciousness. Results of empirical studies on hallucinogens of the first and second order, sensory deprivation, hypnagogic states, hypnotic procedures, and sensory overload]. Berlin, Germany: VWB.
5. Bodmer I, Dittrich A, Lamparter D (1994) Aussergewöhnliche Bewusstseinszustände - Ihre gemeinsame Struktur und Messung [Altered states of consciousness - Their common structure and assessment]. In: Hofmann A, Leuner H, eds. Welten des Bewusstseins. Bd. 3, Experimentelle Psychologie, Neurobiologie und Chemie. Berlin, Germany: VWB. pp 45-58.
6. Dittrich, A, Lamparter, D, Maurer, M (2006) 5D-ABZ: Fragebogen zur Erfassung Aussergewöhnlicher Bewusstseinszustände. Eine kurze Einführung [5D-ASC: Questionnaire for the assessment of altered states of consciousness. A short introduction]. Zurich, Switzerland: PSIN PLUS.
7. Dittrich, A, Lamparter, D, Maurer, M (2010) 5D-ASC: Questionnaire for the assessment of altered states of consciousness. A short introduction. Zurich, Switzerland: PSIN PLUS.
8. Griffiths RR, Richards WA, McCann U, Jesse R (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 187: 268-283. 10.1007/ s00213-006-0457-5.
9. Northoff G, Richter A, Bermpohl F, Gnimm S, Martin E, et al. (2005) NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in MRI. Schizophr Res 72: 235-248. 10.1016/j.schres.2004.04.009.
10. Hasler F, Studerus E, Lindner K, Ludewig S, Vollenweider FX (2009) Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. J Psychopharmacol 23: 923-935. 10.1177/ 0269881108094650.
11. Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, et al. (2005) Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): A double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry 38: 301-311. 10.1055/s-2005-916185.
12. Gouzoulis-Mayfrank E, Habermeyer E, Hermle L, Steinmeyer AM, Kunert HJ, et al. (1998) Hallucinogenic drug induced states resemble acute endogenous psychoses: Results of an empirical study. Eur Psychiatry 13: 399-406. 10.1016/ S0924-9338(99)80686-5.
13. Kjellgren A, Sundequist U, Sundholm U, Norlander T, Archer T (2004) Altered consciousness in flotation-REST and chamber-REST: Experience of experimental pain and subjective stress. Soc Behav Pers 32: 103-115. 10.2224/ sbp.2004.32.2.103.
14. Walach H, Kaseberg E (1998) Mind machines: A controlled study on the effects of electromagnetic and optic-acoustic stimulation on general well-being, electrodermal activity, and exceptional psychological experiences. Behav Med 24: 107-114. 10.1080/08964289809596388.
15. Hübner C (2007) EnTrance: Entrance to wider worlds, or mystification of mere relaxation? Music Therapy Today 8: 257-293.
16. Dittrich A (1994) Psychological aspects of altered states of consciousness of the LSD type: Measurement of their basic dimensions and prediction of individual differences. In: Pletscher A, Ladewig D, eds. 50 Years of LSD: Current status and perspectives of hallucinogens. New YorkNY: Parthenon. pp 101-118.
17. Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004) Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose-effect study. Psychopharmacology (Berl) 172: 145-156. 10.1007/s00213-003-1640-6.
18. Vollenweider FX, Vontobel P, Hell D, Leenders KL (1999) 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man: A PET study with [C-11]raclopride. Neuropsychopharmacology 20: 424-433. 10.1016/S0893-133X(98)00108-0.
19. Umbricht D, Koller R, Vollenweider FX, Schmid L (2002) Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 51: 400-406. 10.1016/S0006-3223(01)01242-2.
20. Stace WT (1961) Mysticism and philosophy. London, England: Macmillan.
21. Dittrich A, Vonarx S, Staub S (1985) International study on altered states of consciousness (ISASC): Summary of the results. Ger J Psychol 9: 319-339.
22. Leuner H (1962) Die experimentelle Psychose [The experimental psychosis]. Berlin, Germany: Springer.
23. Leuner H (1981) Halluzinogene: Psychische Grenzzustände in Forschung und Psychotherapie [Hallucinogens: Psychological borderline states in research and psychotherapy]. Berne, Switzerland: Huber.
24. Bodmer I (1999) Erinnerung an einen aussergewöhnlichen Bewusstseinszustand: Eine experimentelle Untersuchung zum autobiographischen Gedächtnis [Recollection of an altered state of consciousness: An experimental study on the autobiographic memory]. Berlin, Germany: VWB.
25. Mavromatis A (1987) Hypnagogia: The unique state of consciousness between wakefulness and sleep. London, England: Routledge & Kegan Paul.
26. Malitz S, Wilkens B, Esecover H (1962) A comparison of drug-induced hallucinations with those seen in spontaneously occurring psychoses. In:West CJ, ed. Hallucinations: behaviour, experience and theory. New York, NY: Grune & Stratton. pp 50-63.
27. Carroll JB (1945) The effect of difficulty and chance success on correlations between items or between tests. Psychometrika 10: 1-19. 10.1007/BF02289789.
28. Kubinger K (2003) On artificial results due to using factor analysis for dichotomous variables. Psychol Sci Q 45: 106-110.
29. Reise SP, Waller NG, Comrey AL (2000) Factor analysis and scale revision. Psychol Assess 12: 287-297. 10.1037/1040-3590.12.3.287.
30. Meredith W (1993) Measurement invariance, factor-analysis and factorial invariance. Psychometrika 58: 525-543. 10.1007/BF02294825.
31. Paunonen SV (1997) On chance and factor congruence following orthogonal Procrustes rotation. Educ PsycholMeas 57: 33-59. 10.1177/0013164497057001003.
32. Barrett PT (2006) Orthosim 2, version 2.1 [computer program].
33. Chan W, Ho RM, Leung K, Chan DKS, Yung YF (1999) An alternative method for evaluating congruence coefficients with Procrustes rotation: A bootstrap procedure. Psychol Methods 4: 378-402. 10.1037/1082- 989X.4.4.378.
34. Little TD, Cunningham WA, Shahar G, Widaman KF (2002) To parcel or not to parcel: Exploring the question, weighing the merits. Struct Equ Modeling 9: 151-173. 10.1207/S15328007SEM0902_1.
35. Marsh HW, Lüdtke O, Muthén B, Asparouhov T, Morin AJS, et al. (2010) A new look at the big-five factor structure through exploratory structural equation modeling. Psychol Assess. In press.
36. Liechti ME, Gamma A, Vollenweider FX (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology (Berl) 154: 161-168. 10.1007/s002130000648.
37. Pekala RJ, Steinberg J, Kumar VK (1986) Measurement of phenomenological experience: Phenomenology of Consciousness Inventory. Percept Mot Skills 63: 983-989. 10.2466/PMS.63.6.983-989.
38. Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994) Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51: 98-108.
39. Asparouhov T, Muthén B (2009) Exploratory structural equation modeling. Struct Equ Modeling 16: 397-438. 10.1080/10705510903008204.
40. Revelle W (1978) ICLUST: A cluster analytic approach to exploratory and confirmatory scale construction. Behav Res Methods 10: 739-742.
41. Vollenweider FX, Geyer MA (2001) A systems model of altered consciousness: Integrating natural and drug-induced psychoses. Brain Res Bull 56: 495-507. 10.1055/s-2007-979353.
42. Geyer MA, Vollenweider FX (2008) Serotonin research: Contributions to understanding psychoses. Trends Pharmacol Sci 29: 445-453. 1016/j.tips.2008.06.006.
43. Fahrenberg J, Hampel R, Selg H (1984) Das Freiburger Persönlichkeitsinventar FPI [The Freiburg Personality Inventory FPI]. Göttingen, Germany: Hogrefe.
44. Johnson M, Richards W, Griffiths R (2008) Human hallucinogen research: Guidelines for safety. J Psychopharmacol 22: 603-620. 10.1177/ 0269881108093587.
45. Russell JA, Carroll JM (1999) On the bipolarity of positive and negative affect. Psychol Bull 125: 3-30.
46. Janke W, Debus G (1986) EWL 60 S. In: CIPS, ed. Internationale Skalen für Psychiatrie. Weinheim, Germany: Beltz. pp 43-47.
47. Janke W, Debus G (1978) Die Eigenschaftswörterliste EWL: Eine mehrdimensionale Methode zur Beschreibung von Aspekten des Befindens [The adjective word list EWL: A multidimensional method for describing aspects of the actual state]. Göttingen, Germany: Hogrefe.
48. Weber CS, Thayer JF, Rudat M, Perschel FH, Buchholz K, et al. (2007) Emotional irritation before mental stress is associated with enhanced peripheral norepinephrine. Scand J Psychol 48: 459-466. 10.1111/j.1467- 9450.2007.00612.x.
49. Wiswede D, Munte TF, Kramer UM, Russeler J (2009) Embodied emotion modulates neural signature of performance monitoring. PLoS ONE 4: e5754. 10.1371/journal.pone.0005754.
50. Spielberger CD, Gorsuch RL (1970) STAI manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists.
51. Laux L, Glanzmann P, Schaffner P, Spielberger CD (1981) Das State-Trait- Angstinventar [The State-Trait Anxiety Inventory]. Weinheim, Germany: Beltz.
52. Spielberger CD, Gorsuch RL, Lushene RE, Vagg PR, Jacobs GA (1983) State- Trait Anxiety Inventory for adults. Palo Alto, CA: Consulting Psychologists.
53. Grös DF, Antony MM, Simms LJ, Mccabe RE (2007) Psychometric properties of the State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA): Comparison to the State-Trait Anxiety Inventory (STAI). Psychol Assess 19: 369-381. 10.1037/1040-3590.19.4.369.
54. Endler NS, Cox BJ, Parker JDA, Bagby RM (1992) Self-reports of depression and state trait anxiety: Evidence for differential assessment. J Pers Soc Psychol 63: 832-838. 10.1037/0022-3514.63.5.832.
55. Vigneau F, Cormier S (2008) The factor structure of the state-trait anxiety inventory: An alternative view. J Pers Assess 90: 280-285.
56. Kvaal K, Laake K, Engedal K (2001) Psychometric properties of the state part of the Spielberger State-Trait Anxiety Inventory (STAI) in geriatric patients. Int J Geriatr Psychiatry 16: 980-986. 10.1002/gps.458.
57. Iwata N, Higuchi HR (2000) Responses of Japanese and American university students to the STAI items that assess the presence or absence of anxiety. J Pers Assess 74: 48-62. 10.1207/S15327752JPA740104.
58. Marsh HW, Muthén B, Asparouhov T, Lüdtke O, Robitzsch A, et al. (2009) Exploratory structural equation modeling, integrating CFA and EFA: Application to students' evaluations of university teaching. Struct Equ Modeling 16: 439-476. 10.1080/10705510903008220.
59. Muthén LK, Muthén BO (2007) Mplus user's guide. Fifth edition. Los Angeles, CA: Muthén & Muthén.
60. Cattell RB (1966) Scree test for number of factors. Multivariate Behav Res 1: 245-276. 10.1207/s15327906mbr0102_10.
61. Horn JL (1965) A rationale and test for the number of factors in factor analysis. Psychometrika 30: 179-185. 10.1007/BF02289447.
62. Velicer WF (1976) Determining the number of components from the matrix of partial correlations. Psychometrika 41: 321-327. 10.1007/BF02293557.
63. Revelle W, Rocklin T (1979) Very simple structure: An alternative procedure for estimating the optimal number of interpretable factors. Multivariate Behav Res 14: 403-414. 10.1207/s15327906mbr1404_2.
64. Raiche G, Magis D (2009) nFactors: Parallel analysis and non graphical solutions to the Cattell scree test, version 2.3.1 [computer program].
65. Revelle W (2009) psych: Procedures for psychological, psychometric, and personality research, version 1.0-85 [computer program].
66. R Development Core Team (2009) R: A language and environment for statistical computing, version 2.10.1 [computer program].
67. Bacon DR (2001) An evaluation of cluster analytic approaches to initial model specification. Struct EquModeling 8: 397-429. 10.1207/S15328007SEM0803_4.
68. Revelle W (1979) Hierarchical cluster-analysis and the internal structure of tests. Multivariate Behav Res 14: 57-74. 10.1207/s15327906mbr1401_4.
69. Cooksey RW, Soutar GN (2006) Coefficient beta and hierarchical item clustering: An analytical procedure for establishing and displaying the dimensionality and homogeneity of summated scales. Organ Res Methods 9: 78-98. 10.1177/1094428105283939.
70. Brown TA (2006) Confirmatory factor analysis for applied research. New York, NJ: Guilford.
71. Woods CM (2009) Evaluation of MIMIC-model methods for DIF testing with comparison to two-group analysis. Multivariate Behav Res 44: 1-27. 10.1080/ 00273170802620121.
72. Fleishman JA, Spector WD, Altman BM (2002) Impact of differential item functioning on age and gender differences in functional disability. J Gerontol B Psychol Sci Soc Sci 57: S275-S284.
73. Woods CM, Oltmanns TF, Turkheimer E (2009) Illustration of MIMIC-model DIF testing with the Schedule for Nonadaptive and Adaptive Personality. J Psychopathol Behav Assess 31: 320-330. 10.1007/s10862-008-9118-9.
74. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289-300.
75. Yuan KH, Bentler PM (2000) Three likelihood-based methods for mean and covariance structure analysis with nonnormal missing data. Sociol Methodol 30: 165-200. 10.1111/0081-1750.00078.
76. Satorra A, Bentler PM (2001) A scaled difference chi-square test statistic for moment structure analysis. Psychometrika 66: 507-514. 10.1007/BF02296192.
77. Hu LT, Bentler PM (1998) Fit indices in covariance structure modeling: Sensitivity to underparameterized model misspecification. Psychol Methods 3: 424-453. 10.1037/1082-989X.3.4.424.
78. Zinbarg RE, Revelle W, Yovel I, Li W (2005) Cronbach's alpha, Revelle's beta, and McDonald's omega H: Their relations with each other and two alternative conceptualizations of reliability. Psychometrika 70: 123-133. 10.1007/s11336- 003-0974-7.
79. Green SB, Yang YY (2009) Commentary on coefficient alpha: A cautionary tale. Psychometrika 74: 121-135. 10.1007/s11336-008-9098-4.
80. Raykov T (2001) Estimation of congeneric scale reliability using covariance structure analysis with nonlinear constraints. Br J Math Stat Psychol 54: 315-323. 10.1348/000711001159582.
81. Raykov T (2009) Evaluation of scale reliability for unidimensional measures using latent variable modeling. Meas Evak Couns Dev 42: 223-232. 10.1177/ 0748175609344096.
82. Raykov T, Marcoulides GA (2004) Using the delta method for approximate interval estimation of parameter functions in SEM. Struct Equ Modeling 11: 621-637. 10.1207/s15328007sem1104_7.
83. McDonald RP (1999) Test theory: A unified treatment. Hillsdale, NJ: Erlbaum.
84. Zinbarg RE, Revelle W, Yovel I (2007) Estimating omega(h) for structures containing two group factors: Perils and prospects. Appl Psychol Meas 31: 135-157. 10.1177/0146621606291558.
85. Duhachek A, Iacobucci D (2004) Alpha's standard error (ASE): An accurate and precise confidence interval estimate. J Appl Psychol 89: 792-808. 10.1037/0021- 9010.89.5.792.
86. Velicer FW, Eaton AC, Fava JL (2000) Construct explication through factor or component analysis: A review and evaluation of alternative procedures for determining the number of factors or components. In: Goffin RD, Helmes E, eds. Problems and solutions in human assessment: Honoring Douglas N. Jackson at seventy. New York, NY: Kluwer.
87. Crawford AV, Green SB, Levy R, Lo WJ, Scott L, et al. (2010) Evaluation of parallel analysis methods for determining the number of factors. Educ Psychol Meas. In press.
88. Muthén LK, Muthén BO (2002) How to use a Monte Carlo study to decide on sample size and determine power. Struct Equ Modeling 9: 599-620.
89. Rossiter JR (2002) The C-OAR-SE procedure for scale development in marketing. Int J Res Mark 19: 305-335. 10.1016/S0167-8116(02)00097-6.
90. Nunnally JC, Bernstein IH (1994) Psychometric theory. New York, NY: McGraw-Hill.
91. Liechti ME, Vollenweider FX (2000) Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans. Eur Neuropsychopharmacol 10: 289-295. 10.1016/S0924-977X(00)00086-9.